SBTi Registry
Explore 1 matching companies with public, verified Science Based Targets commitments.
Data sourced from the Science Based Targets initiative (SBTi).
| Sector | Region | Near-Term Status | Size | ||||
|---|---|---|---|---|---|---|---|
| Amgen Inc. | Pharmaceuticals, Biotechnology and Life Sciences | Northern America | Targets set | Large | 3 | Sep 22, 2022 | |
Near-Term Status Targets set Near-Term Classification 1.5°C Near-Term Target Year 2030 Long-Term Status - Net-Zero Status - Net-Zero Year - Sector Pharmaceuticals, Biotechnology and Life Sciences Region Northern America Organization Type Corporate Location United States of America Company Size Large Target Statement Amgen commits to reduce absolute scope 1 and 2 GHG emissions 55% by 2027 from a 2019 base year. Amgen also commits to increase annual sourcing of renewable electricity from 29% in 2019 to 100% by 2027, to continue annually sourcing of 100% renewable electricity through 2030. Amge… Stakeholders David Seitz Director, Global Environment, Health, Safety and Sustainability Director, Environment, Health, Safety and Sustainability Executive Director, Environmental Social Governance (ESG) | |||||||
Turn Commitments Into Impact
Thousands of companies have set public Scope 3 emissions-reduction targetsthrough SBTi, but few have the tools to deliver on them. Carbon3 gives you the infrastructure to plan, track, and execute the supply-chain decarbonization work behind your commitment, turning a public pledge into measurable progress. See how it works.